3rd Nov 2015 07:00
Collagen Solutions Plc
(the "Company" or the "Group")
Notice of Half Year Results
Analyst Briefing
The Board of Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, will announce their unaudited interim results for the six months ending 30 September 2015 on Tuesday, 1 December 2015.
A briefing for analysts will take place at Walbrook PR, 4 Lombard Street, London EC3V 9HD at 9.30am on Tuesday 1 December 2015.
If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email [email protected].
Enquiries:
Collagen Solutions Plc | ||
David Evans, Chairman | Tel: 07740 084 452 | |
Stewart White, CEO | Tel: 0141 648 9100 | |
Panmure Gordon | ||
Robert Naylor (Corporate Finance) | Tel: 020 7886 2500 | |
Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] | |
Mike Wort | Mob: 07900 608 002 | |
Anna Dunphy | Mob: 07876 741 001 | |
Related Shares:
COS.L